Spotlight Clinical, Medical & Diagnostic Products New Turkish IVF Lab Equipped
IKS International has supplied all the sample storage and security equipment at the new BAHCECI Fulya IVF centre in Istanbul following a highly successful joint project with their Turkish distributors Gonagen. The package includes 17 controlled-atmosphere incubators (CO2/O2 and CO2) integrated with IKS’ state- of-the art XiltriX® monitoring, logging and alarm system.
Significant factors in the choice of the IKS triple-gas incubators were exceptional value for money and their very fast recovery times after door opening, providing a very stable environment for vulnerable samples. Equally important, however, was the added value provided by IKS’ expertise in laboratory monitoring and in managing projects to deliver complete laboratory solutions.
The Fulya IVF centre was established by the Bahceci group, a well-known organisation in this field in Turkey and surrounding countries. IKS equipment is also used in other, smaller laboratories in Turkey, Kosovo and Iraq.
Gonagen is a specialised distributor of hospital and medical laboratory equipment and is the sole distributor of IKS branded products in Turkey, Azerbaijan, Cyprus, Kosovo and Iraq. Han Weerdesteyn, IKS Product Manager said: “We are very happy to work with Gonagen to develop equipment and monitoring solutions. Their professional approach to handling projects like this is a formula for future success.”
Circle no. 73
Regulatory Approval for New Ovarian Cancer Diagnostic Test
A new diagnostic tool, which studies show can aid in determining the risk of whether a pelvic mass is benign or malignant, is now available in Europe. This simple blood test is expected to help in the assessment of epithelial ovarian cancer, the most lethal form of gynecological cancer. This important immunoassay, which will run on Abbott Diagnostics ARCHITECT systems, is the first automated HE4
test.Research has shown that this novel diagnostic marker, combined with other tests such as the CA125 assay, can aid in measuring the risk of epithelial ovarian cancer in pre- and post-menopausal women who have a pelvic mass.
According to the International Agency for Research on Cancer, the five-year survival rate of ovarian cancer patients is 46 percent. However, when the disease is diagnosed earlier, the survival rate increases to 94 percent.
"The ability of this test to help physicians predict whether a pelvic mass is benign or malignant is an important development for both patients and physicians," said Brian Blaser, Senior Vice President, Diagnostics, Abbott. "Abbott's ARCHITECT HE4 test will aid physicians in determining the most appropriate treatment for their patients." Abbott partnered with Fujirebio Diagnostics, Inc in the development of the assay. The test is now available in several European countries, as well as in some countries in Asia Pacific and Latin America and recently received FDA clearance in the United States.
Circle no. 74
Vital Work in Cancer Research
Qlucore has announced that Dr Helena Carén has been using Qlucore Omics Explorer to research tumour growth and treatment whilst at the Department of Clinical Genetics, Institute of Biomedicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
The Sahlgrenska Academy is the faculty of health sciences at the University of Gothenburg, where education and research are conducted within the fields of pharmacy, medicine, odontology and health care sciences. Dr Carén has been using the Qlucore software to analyse methylation data from the Illumina platform in order to identify patterns that could help to categorise tumours into different categories of seriousness, and also to predict how the tumour is likely to develop.
Culture Media Preparation New
APS One A r
True Walk A
rueWalk Away Aut High capacity
High capacity Per ec
erfect homogenisation and level even f Ergo
Visit us at Medica Booth 3D84
Booth 3D84 onomic and compaconomic and compact APS One ® A revolutionaryary technology olutionary echnolog
y Automated P ty
ed Pourer er Stacker for Petri dishes
10 or 14 litres agar dispensed in one cycle (560 or 800 plates) Outstanding plates quality
10 or 14 litres agar dispensed in one cycle (560 or 800 plates) Outstanding plates quali yt
enisation and level even for low vo ume pl esolume platl rStacker or etri dishesPf Ne New c ncept New concept ewco New Artificial Cerebrospinal Fluid
Artificial Cerebrospinal Fluid (CSF) closely matches the electrolyte concentrations and osmolality found in authentic cerebrospinal fluid.
Artificial CSF is commonly used as a sterile diluent or flushing fluid for delivery of molecules into the brain. It can also be used when sampling brain interstitial fluid.
Artificial CSF manufactured by Harvard Apparatus is perfect for use as a general infusate or perfusate, when it is essential for fluid to be identical in composition to native CSF.
www
w..aeschemunex.com Circle no. 76
Prepared with highest purity water and analytical grade chemicals, artificial CSF is supplied in convenient, sterile 25ml aliquots.
Circle no. 77
"It is often very difficult to find meaningful patterns in very large datasets like these, but Qlucore's software has made it much easier for me to understand the relevance of the data produced during my methylation analysis," said Helena Carén, PhD. "The 3D graphics, in particular, have been very helpful, since it is easier to spot important patterns when you can view your results as a 3D image, and even rotate the image, if needed, directly on the computer screen." The ultimate goal of the methylation study is to identify a set of genes whose methylation profile can accurately determine how aggressive a tumour is, as well as the most effective method of treatment. In the longer term, these studies will also help to identify the specific genes that have contributed to formation of the tumour itself.
Qlucore's highly intuitive Qlucore Omics Explorer application adds increased creativity to this kind of research, thanks to the software's impressive speed and statistical capability. Qlucore Omics Explorer has already gained a global reputation within the scientific community, as it allows the actual researchers – the people with the most biological insight – to study the data and to look for patterns and structures. In addition, because Qlucore Omics Explorer allows researchers to explore different hypotheses and alternative scenarios within seconds, the software is already helping to play a key role in unveiling important new discoveries.
Circle no. 75
IA234B
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
